These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 959827)

  • 1. Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2.
    Ellis EF; Oelz O; Roberts LJ; Payne NA; Sweetman BJ; Nies AS; Oates JA
    Science; 1976 Sep; 193(4258):1135-7. PubMed ID: 959827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboxane A2 and prostaglandin H2: potent stimulators of the swine coronary artery.
    Svensson J; Hamberg M
    Prostaglandins; 1976 Dec; 12(6):943-50. PubMed ID: 1005743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral arterial smooth muscle contraction by thromboxane A2.
    Ellis EF; Nies AS; Oates JA
    Stroke; 1977; 8(4):480-3. PubMed ID: 898244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of thromboxane A2 by non-aggregating dog platelets challenged with arachidonic acid or with prostaglandin H2.
    Chignard M; Vargaftig BB
    Prostaglandins; 1977 Aug; 14(2):222-40. PubMed ID: 197571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-0164 inhibits generation of thromboxane-A2-like activity from prostaglandin endoperoxides by human platelet microsomes.
    Kulkarni PS; Eakins KE
    Prostaglandins; 1976 Sep; 12(3):465-9. PubMed ID: 968059
    [No Abstract]   [Full Text] [Related]  

  • 6. Diversion of prostaglandin endoperoxide metabolism by selective inhibition of thromboxane A2 biosynthesis in lung, spleen or platelets.
    Nijkamp FP; Moncada S; White HL; Vane JR
    Eur J Pharmacol; 1977 Jul; 44(2):179-86. PubMed ID: 407090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the formation and effects of thromboxane A2 in human platelets.
    Svensson J; Hamberg M; Samuelsson B
    Acta Physiol Scand; 1976 Nov; 98(3):285-94. PubMed ID: 998278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboxanes: selective biosynthesis and distinct biological properties.
    Needleman P; Minkes M; Raz A
    Science; 1976 Jul; 193(4248):163-5. PubMed ID: 945611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary tone modulation: formation and actions of prostaglandins, endoperoxides, and thromboxanes.
    Needleman P; Kulkarni PS; Raz A
    Science; 1977 Jan; 195(4276):409-12. PubMed ID: 831285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides.
    Needleman P; Moncada S; Bunting S; Vane JR; Hamberg M; Samuelsson B
    Nature; 1976 Jun; 261(5561):558-60. PubMed ID: 934294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin endoperoxides and thromboxanes: formation and effects.
    Moncada S
    Naunyn Schmiedebergs Arch Pharmacol; 1977; 297 Suppl 1():S81-4. PubMed ID: 859657
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective inhibitory actions of sodium-p-benzyl-4-[1-oxo-2-(4-chlorobenzyl)-3-phenyl propyl] phenyl phosphonate (N-0161) and indomethacin on the biosynthesis of prostaglandins and thromboxanes from arachidonic acid.
    Eakins KE; Kulkarni PS
    Br J Pharmacol; 1977 May; 60(1):135-40. PubMed ID: 884384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubilization and resolution of thromboxane synthesizing system from microsomes of bovine blood platelets.
    Yoshimoto T; Yamamoto S; Okuma M; Hayaishi O
    J Biol Chem; 1977 Aug; 252(16):5871-4. PubMed ID: 885887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin endoperoxides and thromboxane A2 can induce platelet aggregation in the absence of secretion.
    Charo IF; Feinman RD; Detwiler TC; Smith JB; Ingerman CM; Silver MJ
    Nature; 1977 Sep; 269(5623):66-9. PubMed ID: 895887
    [No Abstract]   [Full Text] [Related]  

  • 15. Persistence of thromboxane A2-like material and platelet release-inducing activity in plasma.
    Smith JB; Ingerman C; Silver MJ
    J Clin Invest; 1976 Nov; 58(5):1119-22. PubMed ID: 993335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
    Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J
    Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of prostagladin endoperoxides and thromboxane A2 on strips of rabbit coeliac artery and certain other smooth muscle preparations [proceedings].
    Bunting S; Moncada S; Vane JR
    Br J Pharmacol; 1976 Jul; 57(3):462P-463P. PubMed ID: 974353
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostaglandin endoperoxides IX. Characterization of rabbit aorta contracting substance (RCS) from guinea pig lung and human platelets.
    Svensson J; Hamberg M; Samuelsson B
    Acta Physiol Scand; 1975 Jun; 94(2):222-8. PubMed ID: 1155178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
    Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
    J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
    Hamberg M; Svensson J; Samuelsson B
    Proc Natl Acad Sci U S A; 1975 Aug; 72(8):2994-8. PubMed ID: 1059088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.